Mechanisms of nucleoside analogue resistance associated with the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms

Documenti analoghi

• Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy
  di: Betancor Gilberto, et al.
  Pubblicazione: (2012-08-01)
• A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity.
  di: David W Wright, et al.
  Pubblicazione: (2013-01-01)
• Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
  di: Esnouf, R, et al.
  Pubblicazione: (1995)
• Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
  di: N. S. Shastina, et al.
  Pubblicazione: (2011-04-01)
• Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
  di: Valeria Famiglini, et al.
  Pubblicazione: (2016-02-01)